This invention is in the field of lymphadenopathy virus, which has been
designated Human Immunodeficiency Virus Type 1 (HIV-1) to detect the
presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus
associated with the acquired immune deficiency syndrome or of the
lymphadenopathy syndrome by the use of DNA fragments or the peptides
encoded by said DNA fragments. The invention further relates tot he DNA
fragments, vectors comprising them and the proteins expressed.